期刊文献+

Gd-DTPA-Dimeglumine的^(99)Tc^m标记及其生物学特性 被引量:4

Preparation of ^(99)Tc^m-Gd-DTPA-Dimeglumine and its Biologic Characteristics
下载PDF
导出
摘要 以氯化亚锡为还原剂,99Tcm一步法标记了顺磁对比剂Gd-DTPA-Di meglumine(钆喷酸二甲葡胺),得到99Tcm-Gd-DTPA-Di meglumine。薄层色谱法(TLC)分析标记物的标记率>95%,可在室温稳定存放6 h,放化纯度>90%;三氯乙酸沉淀法测定99Tcm-Gd-DTPA-Di meglumine的体外血浆蛋白结合率为2.25%±0.21%。小鼠体内生物分布结果显示,99Tcm-Gd-DTPA-Di meglumine主要经肾脏排泄,脑和肌肉组织摄取最少,所有脏器在注射后1 min摄取达高峰,注射后5 min滞留率下降大于50%,注射后30~60 min标记药物在主要脏器内滞留很少。家兔肾动态显像结果显示,99Tcm-Gd-DTPA-Di meglumine主要经肾脏排泄,达高峰时间约5 min,半排时间约7 min。99Tcm标记Gd-DTPA-Di meglumine方法简单,标记效率高,Gd-DTPA-Di meglumine经99Tcm标记后其生物学性质基本未改变。本实验表明可以通过双功能螯合剂DTPA同时链接放射性核素99Tcm和顺磁性金属元素Gd,并有望在此基础上合成一种具有较好靶向性又可同时进行核医学SPECT和MRI增强扫描的显像剂。 The purpose of this study was to evaluate the feasibility of Gd-DTPA-Dimeglumine, as a contrast enhancer in magnetic resonance imaging(MRI). It was labeled with ^99Tc^m, and its biologic characteristics was observed. The radiochemical purity and the stability of ^99Tc^m-Gd_DTPA-Dimeglumine were measured by TLC. The labeling yield of ^99Tc^m- Gd-DTPA-Dimeglumine was 〉95 % and stable for at least 6 h at room temperature with the radiochemical purity more than 90%. The plasma protein binding rate of ^99Tc^m-Gd-DTPA- Dimeglumine was 2.25%±0. 21%. The biodistribution in mice showed that ^99Tc^m-Gd-DTPA-Dimeglumine was excreted through kidney. The time of the highest uptake in all of the major organs was at 1 min after injection, and the decrease of deposition was more than 50% at 5 min after injection, and the brain and muscles had the lowest uptake rate which was less than 1%. The major organs had little uptake at 30-60 min after injection. Renal dynamic scintigraphy in rabbits were administrated via intravenous injection. The results indicated that ^99Tc^m Gd-DTPA-Dimeglumine was quickly excreted by kidney, and the time to peak was about 5 min, the half time of clearance was about 7 min. It was a sample method with high labeling yield and radiochemical purity that Gd-DTPA-Dimeglumine labeled with ^99Tc^m and its biodistribution was not changed on the whole after labeled. The study indicated that DTPA as a bifunctional chelator may be linked with ^99Tc^m and Gd. As a type of new multimodality imaging agents with higher targeting characteristics, it could he applied both in SPECT and MRI scan.
出处 《同位素》 CAS 2009年第3期149-155,共7页 Journal of Isotopes
基金 2008年四川省医学重点学科建设项目(2008-17) 四川省杰出青年学科带头人基金资助项目(2008-46-386)
关键词 99Tcm标记 DTPA 钆喷酸二甲葡胺 生物学分布 ^99Tc^m Gd-DTPA-Dimeglumine DTPA gadolinium DTPA dimeglumine biodistribution
  • 相关文献

参考文献11

  • 1Prato FS, Wisenberg G, Marshall TP, et al. Comparison of the biodistribution of gadolinium-153 DTPA and technetium-99m DTPA in rats[J]. J Nucl Med, 1988, 29(10):1 683-1 687.
  • 2Russell CD, Bischoff PG, Rowell KL, et at. Quality control of Tc-99m DTPA for measurement of glomerular filtration: concise communication[J]. J Nucl Med, 1983, 24(8): 722-727.
  • 3Russell CD, Rowell K, Scott JW. Quality control of technetium-99m DTPA: correlation of analytic tests with in vivo protein binding in man [J]. J Nucl Med, 1986, 27(4): 560-562.
  • 4Rootweh K, Falch D, Sjokvist R. Determination of glomerular filtration rate (GFR) by analysis of capillary blood after single shot injection of ^99mTcDTPA[J]. Eur J Nucl Med, 1980, 5(2): 97-102.
  • 5Arheden H, Saeed M, Higgins CB, et al. Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with ^99mTc-DTPA autoradiography in rats[J]. Radiology, 1999, 211(3): 698-708.
  • 6Weinmann H J, Brasch RC, Press WR, et al. Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent [J]. Am J Roentgenol, 1984, 142(3): 619-624.
  • 7李明,林祥通,程伟,管一晖,施孝金,郑传钧.^(153)Gd—DTPA的合成及其在小鼠体内分布的实验研究[J].核技术,1995,18(5):278-281. 被引量:2
  • 8Agha N, Persson RB. Comparative labelling and biokinetic studies of ^99mTc-EDTA (Sn) and ^99mTc- DTPA(Sn) [J]. Nuklearmedizin, 1977, 16 (1): 30-35.
  • 9Boutry S, Burtea C, Laurent S, et al. Magnetic resonance imaging of inflammation with a specific selectin-targeted contrast agent[J]. Magn Reson Med, 2005, 53(4): 800-807.
  • 10Feng Y, Zong Y, Ke T, et al. Pharmacokinetics, biodistribution and contrast enhanced MR blood pool imaging of Gd-DTPA cystine copolymers and Gd-DTPA cystine diethyl ester copolymers in a rat model[J].Pharm Res, 2006, 23(8): 1 736-1 742.

二级参考文献1

共引文献1

同被引文献34

  • 1陈跃,黄占文,何菱,郑时龙,李举联,秦大莲.^(99)Tc^m-DTPA-DG的制备及其荷瘤裸鼠实验研究[J].中华核医学杂志,2005,25(3):176-178. 被引量:28
  • 2熊青峰,陈跃,何菱,黄占文,李举联,邓存良.^(188)Re-DTPA-DG致MCF-7乳腺癌细胞凋亡实验研究[J].中华核医学杂志,2006,26(3):145-148. 被引量:5
  • 3陈跃,熊青峰,何菱,黄占文,郑时龙,李举联,秦大莲.^(188)Re-DTPA-DG的制备及其在荷瘤裸鼠体内的分布[J].同位素,2007,20(1):33-35. 被引量:1
  • 4Townsend DW.Dual-modality imaging:combining anatomy and function[J].J Nucl Med,2008,49(6):938-955.
  • 5Hasegawa BH,Iwata K,Wong KH,et al.Dual-modality imaging of function and physiology[J].Acad Radiol,2002,9(11):1305-1321.
  • 6Cho ZH,Son YD,Kim HK,et al.A fusion PET-MRI system with a high-resolution research tomography-PET and ultra-high field 7.0T-MRI for the molecular-genetic imaging of the brain[J].Proteomics,2008,8(6):1302-1323.
  • 7Choi JS,Park JC,Nah H,et al.A hybrid nanoparticle probe for dual-modality positron emission tomography and magnetic resonance imaging[J].Angew Chem Int Ed Engl,2008,47(7):6259-6262.
  • 8Lee HY,Li Z,Chen K,et al.PET/MRI dual-modality tumor imaging using arginine-glycine-aspartic(RGD)-conjugated radiolabled iron oxide nanoparticles[J].J Nucl Med,2008,49(8):1371-1379.
  • 9Kristof K,Tatjana N,Sophie L,et al.Potential MRI Contrast Agents Based on Micellar Incorporation of Amphiphilic Bis(alkylamide) Derivatives of[(Gd-DTPA)(H2O)] 2-[J].Eur J Inorg Chem,2003,16(9):3021-3027.
  • 10Li C,Wang W,Wu Q,et al.Dual optical and nuclear imaging in human melanoma xenografts using a single targeted imaging probe.Nucl Med Biol,2006,33(3):349-358.

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部